SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (7906)5/7/1998 6:00:00 PM
From: DaiS  Read Replies (1) of 23519
 
Frostman,

2205 on the pfizer thread says pfizer close to obtaining regulatory approval for OVER THE COUNTER sales of viagra here in the UK. How do you think this might impact on muse. Men buying viagra without visiting their doctor may lose out possibility of being exposed to muse unless vivus is more aggressive.

There was another hour long TV programme here today. Men with dfferent forms of impotence were interviewed, as were men with experience of viagra, muse, caverject, pumps, implants. Muse was portrayed as being effective. Viagra also portrayed as effective on some men but causing blinding headaches.

I saw an abstract by vivus scientific team (and others) on experiments with two drugs in the pellet rather than aprostadil alone. There seemed to be an enhanced effect at lower drug doses.

DaiS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News